Latest Mergers And Acquisitions News

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart technology, reporting promising clinical results in Crohn’s disease and GVHD, alongside a $3.5 million capital raise to fuel next-stage development.

Elsight Limited has raised A$60 million through a strongly supported placement, marking a milestone with consecutive record revenues and cash flow breakeven. The company is poised to capitalize on surging defence budgets and expanding drone markets with a robust pipeline of opportunities.

Elsight Limited reports record-breaking revenue growth in Q2 and H1 2025, driven by major defence contracts and expanding market opportunities, positioning the company for profitability later this year.

Elsight Limited reports a record 340% revenue surge to US$4.8 million in the first half of 2025, backed by a robust US$11.45 million contract backlog and a strategic A$60 million capital raise to fuel expansion.

American West Metals reports significant copper sulphide discoveries and thick mineralised intersections at its Storm Copper Project in Nunavut, Canada, highlighting strong potential for resource expansion.

Sarama Resources has completed the acquisition of an 80% stake in the Mt Venn Gold Project, boosting its Laverton landholding to 1,000km² across two major projects. The move positions Sarama to explore promising gold and base metal targets in a prolific Australian gold district.

Austco Healthcare reports robust FY25 growth with revenue climbing over 37% and EBITDA soaring by more than 54%, fueled by strong organic performance and key acquisitions.

AdAlta Limited has prioritized two promising CAR-T cellular immunotherapy products for licensing agreements and successfully raised $1.3 million to support its strategic expansion. The company’s focused capital management and pipeline refinement signal a pivotal phase in its ‘East to West’ strategy.

One Click Group Limited has outpaced its entire July 2024 revenue within the first 18 days of July 2025, defying a broader decline in tax lodgements and showcasing strong customer loyalty.

Alligator Energy reports a 10% increase in indicated uranium resources at its Samphire Project, secures a $17.25 million capital raise, and announces a CEO transition as it advances key uranium exploration and development milestones.

Paladin Energy reported a $18.4 million operating cash outflow in Q2 2025 but maintains a strong liquidity position with $89 million in cash and $139 million in total available funding.

Race Oncology has safely treated the first patient with its RC220 drug alone and in combination with doxorubicin in a Phase 1 trial, while bolstering its clinical leadership and maintaining a strong cash position to fund operations through 2026.